Inozyme Pharma, Inc. - Filer Information

Symbol
INZY on Nasdaq
Entity
Company
CIK
0001693011
EIN
475129768
Business address
321 Summer Street, Suite 400, 02210 Boston, MA
Phone
857-330-4340
State of incorporation
DE
Fiscal year end
December 31
Category
Non-accelerated filer
Smaller reporting company
Emerging growth company
Former names
Inozyme Pharma, LLC (to 1/5/2017)
Signature
/s/ Axel Bolte, as attorney-in-fact for Sarah Bhagat
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Get insider transactions for this reporting owner
Get financial reports for this company